Figure 4.
Survival probability after allogeneic HCT by IBMFS variant status and conditioning intensity. (A) Myeloablative and (B) reduced-intensity conditioning and nonmyeloablative Kaplan-Meier curve comparing 3 groups of patients, those with a previously unrecognized IBMFS (green), carriers (red), and those with no variants (blue).